Tscan Therapeutics, Inc. · NASDAQ:TCRX

BVF PARTNERS L P/IL reported a 9.99% stake in Tscan Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 15, 2025

BVF PARTNERS L P/IL reported a 9.99% stake in Tscan Therapeutics, Inc., 5,263,541 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).

Stake
9.99%
Shares
5,263,541
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P6.40%3,351,425
BVF I GP LLC6.40%3,351,425
BIOTECHNOLOGY VALUE FUND II LP2.90%1,505,307
BVF II GP LLC2.90%1,505,307
Biotechnology Value Trading Fund OS LP0.60%306,903
BVF Partners OS Ltd.0.60%306,903
BVF GP HOLDINGS LLC9.20%4,856,732
BVF PARTNERS L P/IL9.99%5,263,541
BVF INC/IL9.99%5,263,541
LAMPERT MARK N9.99%5,263,541

Source

View original at SEC

Related